(2R,3R,4S,5R)-2-(2-chloro-6-(3-iodobenzylamino)-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydrofuran-3,4-diol

ID: ALA4081182

PubChem CID: 137648795

Max Phase: Preclinical

Molecular Formula: C19H19ClIN9O3

Molecular Weight: 583.78

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(I)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1

Standard InChI:  InChI=1S/C19H19ClIN9O3/c1-2-30-27-16(26-28-30)14-12(31)13(32)18(33-14)29-8-23-11-15(24-19(20)25-17(11)29)22-7-9-4-3-5-10(21)6-9/h3-6,8,12-14,18,31-32H,2,7H2,1H3,(H,22,24,25)/t12-,13+,14-,18+/m0/s1

Standard InChI Key:  YCFJBJJRZOIEFY-MOROJQBDSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   32.2939  -17.2580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2928  -18.0854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0075  -18.4982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0057  -16.8453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7212  -17.2544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7214  -18.0854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5118  -18.3420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0002  -17.6695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5114  -16.9974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7670  -19.1266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2845  -19.7946    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7696  -20.4619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5542  -20.2067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5538  -19.3818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5149  -21.2466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7337  -21.5018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.7339  -22.3268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5186  -22.5815    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0032  -21.9139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7738  -23.3660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2220  -23.9793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2217  -20.6913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.2210  -18.8965    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.0033  -16.0203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.7165  -15.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7141  -14.7807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4292  -14.3706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4270  -13.5463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7108  -13.1351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9952  -13.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0009  -14.3771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2781  -13.1464    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   31.5780  -18.4973    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  4  1  2  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10  7  1  1
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 12 15  1  1
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 15  2  0
 18 20  1  0
 20 21  1  0
 13 22  1  6
 14 23  1  6
  4 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 30 32  1  0
  2 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4081182

    ---

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 583.78Molecular Weight (Monoisotopic): 583.0344AlogP: 1.69#Rotatable Bonds: 6
Polar Surface Area: 148.92Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.30CX Basic pKa: 1.96CX LogP: 2.86CX LogD: 2.86
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.23Np Likeness Score: -0.81

References

1. Petrelli R, Scortichini M, Kachler S, Boccella S, Cerchia C, Torquati I, Del Bello F, Salvemini D, Novellino E, Luongo L, Maione S, Jacobson KA, Lavecchia A, Klotz KN, Cappellacci L..  (2017)  Exploring the Role of N6-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇.,  60  (10): [PMID:28447789] [10.1021/acs.jmedchem.7b00291]

Source